AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The article discusses the rise of AI and its impact on jobs, while also highlighting Moderna's biotechnology company, which specializes in researching and developing therapeutics and vaccines for various diseases. The company's portfolio includes 37 products in clinical development, with 10 in phase I, 18 in phase II, and 9 in phase III. Net sales are distributed geographically across the United States, Europe, and other regions.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet